Glioblastoma — device options
14 open options
- TRIALPHASE3RECRUITING
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
Bevacizumab · Microbubble · Low-Intensity Focused Ultrasound — 2 sites
- TRIALNARECRUITING
Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
Oncomagnetic device — 6 sites
- TRIALPHASE2NOT_YET_RECRUITING
Pharmacoscopy for Patients With Refractory Primary Brain Tumors
Pharmacoscopy 1.0 — 3 sites
- TRIALNARECRUITING
Preoperative Preradiotherapy TTFields
TTFields — 1 site
- TRIALPHASE1NOT_YET_RECRUITING
Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac
MR-Linac System · Radiation Therapy · Temozolomide — 1 site
- TRIALNANOT_YET_RECRUITING
Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM)
MRS study · blood samples — 1 site
- TRIALNARECRUITING
Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
Sonobiopsy · Research blood · Cancer Personalized Profiling — 1 site
- TRIALNANOT_YET_RECRUITING
A Study for Cerebral Open Flow Microperfusion
Cerebral open flow microperfusion — 1 site
- TRIALNANOT_YET_RECRUITING
Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery
Neuropixel probe recording
- TRIALPHASE1 / PHASE2RECRUITING
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
Near-Infrared Fluorescence Imaging · Panitumumab · Panitumumab-IRDye800 — 1 site
- TRIALNARECRUITING
TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0)
Tumor Treating Fields (TTFields) · FET-PET-Guided Stereotactic Radiosurgery — 1 site
- TRIALPHASE3RECRUITING
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
SonoCloud-9 (SC9) · Carboplatin · Lomustine — 55 sites
- TRIALPHASE1RECRUITING
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Dual-target CAR-NK cells · Cyclophosphamide · Fludarabine — 1 site
- TRIALNARECRUITING
Non-invasive Glioma Characterization Through Molecular Imaging
3T MRI Scanner — 1 site
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.